I-Mab and Jiangsu Nhwa collaborate with Biodextris and Ann Romney CND
Category: #health  By Mateen Dalal  Date: 2019-04-08
  • share
  • Twitter
  • Facebook
  • LinkedIn

I-Mab and Jiangsu Nhwa collaborate with Biodextris and Ann Romney CND

The strategic partnership is aimed at jointly developing a new immuno-stimulatory therapy for certain neurologic disorders.

I-Mab Biopharma, a Shanghai-based biotech company, along with the CNS (Central Nervous System) drug development company Jiangsu Nhwa Pharmaceutical, has signed a collaborative research agreement with the world-recognized scientists and clinicians at Biodextris, the biologics contract development & manufacturing organization, and Ann Romney CND (Center for Neurologic Diseases) at Brigham and Women’s Hospital.

Reportedly, the strategic partnership is aimed at jointly developing a new immuno-stimulatory therapy for certain neurologic disorders, with the deployment of the natural power of the immune system. As per the terms of the agreement, the parties are expected to combine their expertise and resources in translational research, basic science, clinical development, manufacturing & commercialization, for speeding up the translation of innovative immunotherapies into the clinic, for some of the most challenging diseases with the greatest unmatched medical needs.

According to a press release issued by I-Mab Biopharma, the Brigham team will be accountable for the preclinical development such as biomarker discovery & validation, and preliminary clinical studies. Biodextris on the other hand, will contribute to CMC development & manufacturing of clinical materials. Sources added that I-Mab and Nhwa will be providing all technical, financial, regulatory and business support for both preclinical and clinical development, along with future commercialization.  

Dr. Zheru Zhang, President, I-Mab, was reportedly quoted saying that the Brigham is globally recognized for its innovation and brilliance in the area of patient care and biomedical research. The latest international collaboration between the industry and a top academic institute is believed to accelerate drug development and scientific advancement as well. He added that I-Mab shares the same goal and has been consistently striving to provide patients around the world with innovative treatments.

Howard L Weiner, Co-director at the Ann Romney Center, said that the advancement of a nasal immune modulator used in vaccines is an exceptional approach towards the treatment of a neurologic disease and moreover, is potent enough to majorly impact the disease prevalence on a global level.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Telenor to sell stake in Myanmar's Wave Money for $53 Mn to Yoma
Telenor to sell stake in Myanmar's Wave Money for $53 Mn to Yoma
By Mateen Dalal

Telenor Group, an international provider of tele, data and media communication services, has reportedly agreed to sell its 51% stake in Myanmar's Wave Money, a provider of digital payment service, for $53 million to Yoma MFS Holdings, a subsidiar...

Alkem to launch state-of-the-art technology to treat DFU in India
Alkem to launch state-of-the-art technology to treat DFU in India
By Mateen Dalal

Alkem Laboratories Ltd. (Alkem), an Indian multinational pharmaceutical company, has reportedly launched a unique patented technology for the treatment of Diabetic Foot Ulcer (DFU) in India. The solution would be based on an innovative technology of...

Bank of America unveils new drive-thru ATM; shuts another in Bethlehem
Bank of America unveils new drive-thru ATM; shuts another in Bethlehem
By Mateen Dalal

According to Andy Aldridge, Bank of America Spokesperson, the financial institutiThe Bank of America Corporation, an American multinational investment bank and financial services, has now opened up a new place for clients in North Bethlehem who are l...